References
- Matsushita T, Maruyama R, Ishikawa N, et al. The number and distribution of eosinophils in the adult human gastrointestinal tract: a study and comparison of racial and environmental factors. Am J Surg Pathol 2015;39:521-527.
- Kinoshita Y, Furuta K, Ishimaura N, et al. Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis. J Gastroenterol 2013;48:333-339.
- Kinoshita Y, Ishimura N, Oshima N, et al. Systematic review: Eosinophilic esophagitis in Asian countries. World J Gastroenterol 2015;21:8433-8440.
- Shoda T, Morita H, Nomura I, et al. Comparison of gene expression profiles in eosinophilic esophagitis (EoE) between Japan and Western countries. Allergol Int 2015;64:260-265.
- Shoda T, Matsuda A, Nomura I, et al. Eosinophilic esophagitis versus proton pump inhibitor-responsive esophageal eosinophilia: Transcriptome analysis. J Allergy Clin Immunol 2017;139:2010-2013.e4.
- Furuta K, Adachi K, Aimi M, et al. Case-control study of association of eosinophilic gastrointestinal disorders with Helicobacter pylori infection in Japan. J Clin Biochem Nutr 2013;53:60-62.
- Sonnenberg A, Dellon ES, Turner KO, et al. The influence of Helicobacter pylori on the ethnic distribution of esophageal eosinophilia. Helicobacter 2017;22. Epub 2016 Dec 28.
- Dellon ES, Jensen ET, Martin CF, et al. Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol 2014;12:589-596.e1.
- Ishimura N, Owada Y, Aimi M, et al. No increase in gastric acid secretion in healthy Japanese over the past two decades. J Gastroenterol 2015;50:844-852.
- Ishimura N, Furuta K, Sato S, et al. Limited role of allergy testing in patients with eosinophilic gastrointestinal disorders. J Gastroenterol Hepatol 2013;28:1306-1313.
- Kinoshita Y, Furuta K, Ishimura N, et al. Elevated plasma cytokines in Japanese patients with eosinophilic esophagitis and gastroenteritis. Digestion 2012;86:238-243.
- Ishihara S, Shoda T, Ishimura N, et al. Serum biomarkers for the diagnosis of eosinophilic esophagitis and eosinophilic gastroenteritis. Intern Med 2017;56:2819-2825.
- Shimura S, Ishimura N, Tanimura T, et al. Reliability of symptoms and endoscopic findings for diagnosis of esophageal eosinophilia in a Japanese population. Digestion 2014;90:49-57.
- Adachi K, Mishiro T, Tanaka S, et al. Suitable biopsy site for detection of esophageal eosinophilia in eosinophilic esophagitis suspected cases. Dig Endosc 2016;28:139-144.
- Okimoto E, Ishimura N, Okada M, et al. Specific locations of linear furrows in patients with esophageal eosinophilia. Dig Endosc 2017;29:49-56.
- Ishimura N, Sumi S, Okada M, et al. Ankylosaurus back sign: novel endoscopic finding in esophageal eosinophilia patients indicating proton pump inhibitor response. Endosc Int Open 2018;6:E165-E172.
- Jiao D, Ishimura N, Maruyama R, et al. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients. J Gastroenterol 2017;52:203-210.
- Wolf WA, Jerath MR, Sperry SL, et al. Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2014;12:1272-1279.
- Lucendo AJ, Serrano-Montalban B, Arias A, et al. Efficacy of dietary treatment for inducing disease remission in eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr 2015;61:56-64.
- Okimoto E, Ishimura N, Okada M, et al. Successful food elimination diet in adult eosinophilic gastroenteritis -case report. ACG Case Reports Journal in press
- Dellon ES, Speck O, Woodward K, et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol 2013;108:1854-1860.
- Ishimura N, Ishihara S, Kinoshita Y. Sustained acid suppression by Potassium-Competitive Acid Blocker (P-CAB) may be an attractive treatment candidate for patients with eosinophilic esophagitis. Am J Gastroenterol 2016;111:1203-1204.
- Sawas T, Dhalla S, Sayyar M, et al. Systematic review with meta-analysis: pharmacological interventions for eosinophilic oesophagitis. Aliment Pharmacol Ther 2015;41:797-806.
- Pineton de Chambrun G, Gonzalez F, Canva JY, et al. Natural history of eosinophilic gastroenteritis. Clin Gastroenterol Hepatol 2011;9:950-956.e1.
- Alexander JA, Ravi K, Enders FT, et al. Montelukast does not maintain symptom remission after topical steroid therapy for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2017;15:214-221.e2.
- Clayton F, Fang JC, Gleich GJ, et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology 2014;147:602-609.
- Markowitz JE, Jobe L, Miller M, et al. Safety and efficacy of reslizumab for children and adolescents with eosinophilic esophagitis treated over nine years. J Pediatr Gastroenterol Nutr 2017 Nov 22. [Epub ahead of print]
- Rothenberg ME, Wen T, Greenberg A, et al. Intravenous antiIL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allergy Clin Immunol 2015;135:500-507.